Splenectomy for benign and malignant hematologic pathology: Modern morbidity, mortality, and long-term outcomes
Background: The role of splenectomy to diagnose and treat hematologic disease continues to evolve. In this single-center retrospective review, we describe modern morbidity, mortality, and long-term outcomes associated with splenectomy for benign and malignant hematologic disorders. Methods: We analy...
Main Authors: | Wilson M Alobuia, MD, Kenneth Perrone, MD, David J Iberri, MD, Rondeep S Brar, MD, David A Spain, MD, Joseph D Forrester, MD, MSc |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Surgery Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589845020300221 |
Similar Items
-
Partial splenectomy followed by total splenectomy in thalassemia
by: Abu Saleh Md. Oli Ullah, et al.
Published: (2017-09-01) -
Blue after splenectomy
by: Taaran Cariappa Ballachanda Subbaiah, MD, et al.
Published: (2017-01-01) -
BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES
by: Giuseppe Leone, et al.
Published: (2015-10-01) -
Laparoscopic splenectomy in children with benign hematological diseases: Leaving nothing behind policy
by: Mohammad Gharieb Khirallah, et al.
Published: (2016-01-01) -
Morbidity- and mortality-related prognostic factors of nontraumatic splenectomies
by: Rajesh Gianchandani Moorjani, et al.
Published: (2014-04-01)